We aim to use what nature has refined over millions of years and apply that to today’s technological challenges
SB3000 AB provide a platform for developing biomimetic technologies, which we believe is the solution to a sustainable eco-friendly future; where health, environmental consciousness and sound economic benefits converge
We are a key player in a fast growing global biomimetics market, launching technologies aimed at three big industrial sectors; pharmaceuticals, automotive and consumer care
Our Commerical Strategy
SB3000 AB’s mission is to form, finance and support technology specific Special Purpose Entities (SPEs) engaged in the development of Intellectual Property (IP) derived from biomimetic concepts.
The working model is to enter into joint development and funding agreements with global, area specific, industrial partners.
The SPEs operate as biotech start-ups where the upcoming revenues are coming from product sales, product/process licenses and royalties. They are run in such a way that they have highly valuable M&A targets or IPO candidates in their own right.
Today, the SB3000 AB Holding portfolio includes two, majority owned, Special Purpose Entities:
Swedish Biomimetics 3000® Aps, µLOT Technologies, Copenhagen, Denmark
Swedish Biomimetics 3000® µMist Technologies Ltd, Devon, United Kingdom